Custom Health Holdings Inc. (TSX: CHLT), a Kelowna-based digital health company, has closed a public offering of units raising aggregate gross proceeds of $10,338,144.30. The offering comprised 2,088,514 units priced at $4.95 each, with each unit including one common share and one warrant exercisable at C$5.90 for 60 months. Notably, CEO Shane Bishop participated directly in the offering, a move the company has disclosed as a related party transaction under applicable securities rules.

Key Points

  • Custom Health Holdings Inc. (TSX: CHLT) is a digital health company focused on in-home medication management technology
  • The company closed a public offering of 2,088,514 units at $4.95 per unit for gross proceeds of $10,338,144.30
  • Each warrant entitles the holder to purchase one common share at C$5.90 for a period of 60 months; Stifel Nicolaus Canada Inc. acted as lead agent and sole bookrunner
  • Investors may be watching how proceeds are deployed toward previously announced acquisitions and planned debt repayments

Offering Structure and Unit Terms for CHLT Shareholders

The offering was completed on November 13, 2026, with Stifel Nicolaus Canada Inc. serving as lead agent and sole bookrunner. Each unit consists of one common share and one warrant, with each warrant carrying a C$5.90 exercise price valid for 60 months from closing. The units were offered across all Canadian provinces and territories except Quebec under a prospectus supplement dated November 11, 2026, filed pursuant to a short form base shelf prospectus dated November 5, 2026. The Agent also offered units to eligible U.S. accredited investors and qualified institutional buyers on a private placement basis under applicable exemptions from U.S. registration requirements.

CEO Shane Bishop Acquires Units, Triggering Related Party Disclosure

Chief Executive Officer and director Shane Bishop participated in the offering by acquiring 282,830 units for an aggregate gross purchase price of $1,400,008.50. The company confirmed this participation constitutes a related party transaction under Multilateral Instrument 61-101. Custom Health states it qualifies for exemptions from formal valuation and minority shareholder approval requirements because neither the fair market value of units issued to Mr. Bishop nor his consideration exceeded 25% of the company's market capitalisation. Further insider participation details will be included in the company's material change report filed in connection with the offering.

How Custom Health Plans to Deploy the Net Proceeds

According to the announcement, net proceeds from the offering will fund payments related to previously announced acquisitions and associated transaction costs, planned debt repayments, general and administrative expenses, and working capital. The company operates the proprietary AdhereNet® platform, which supports medication delivery, medication-use insights, and pharmacist-led care across an integrated pharmacy network in Canada and the United States. The common shares comprising the units have been listed on the Toronto Stock Exchange, while the common shares underlying the warrants have received conditional TSX approval for listing.